Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion from a ...

Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion.

The decision to build versus buy shouldn't be taken lightly, but it shouldn't be avoided either. Smart organizations follow a ...

Investment management company Stanley-Laman Group, Ltd. disclosed a new position in Arista Networks ( ANET +0.40%), acquiring ...

Bryn Talkington, Managing Partner of Requisite Capital Management, explained in a recent program on CNBC why she sold her ...

Hamilton Point Investment Advisors added 33,390 shares in Salesforce, an estimated $7.93 million trade based on average ...

INTU serves as Oracle's counterpart in the Application Software sector, which possesses: 1) A lower valuation (P/OpInc) in comparison to Oracle stock 2) However, it demonstrates superior revenue and ...

Since bottoming out in late 2022, Palantir Technologies (NASDAQ: PLTR) stock has risen by a remarkable 2,700%. And with a run like that behind it, new investors might naturally wonder if the stock is ...

Palantir stock has a solid track record of surprising on earnings. In three of the past four quarters, PLTR stock has jumped ...

CRM's AI momentum, profitability gains and resilient performance make it the stronger buy over ADBE in the cloud software ...

Veeam Software has agreed to buy data privacy management software maker Securiti AI for about $1.73 billion, in a bid to tap ...

The stock carries a premium price tag. After posting incredible returns in 2023 and 2024, Palantir (NASDAQ: PLTR) stock has ...